CC
Insider
Carrie Smith Cox
Executive ChairCarrie Smith Cox (Executive Chair) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in Organon & Co. (OGN). Across 1 priced purchase filing, the average 21-session return was -1.6% from execution and -6.4% from disclosure (delay-adjusted; derived). The largest single filing was $2.7M of TXN (8,838 sh across 2 lots, as filed), executed May 13.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-1.6%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-6.4%
same 1 filings, from disclosure
Filings, ttm
2
1 buys · 1 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.2M
shares × price, as filed
Last traded
May 13
Filed May 14
Median ADV $1.2B across their filed names
Open performance→Volume by month
Buys $602K
Sells $2.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Technology
1 filing
Sector per market data · by filing · past 12 months
Most traded names
OGNRecent filings
TXNSALE
Texas Instruments Incorporated
View filing →
$2.7M8,838 sh across 2 lots
Exec May 13
Filed May 14 · 5:30 PM ET OGNPURCHASE Organon & Co. View filing → $502K
65,400 sh × $7.67
Exec Nov 12 2025
Filed Nov 13 2025 · 4:05 PM ET OGNPURCHASE Organon & Co. View filing → $101K
12,469 sh × $8.07
Exec May 14 2025
Filed May 15 2025 · 5:30 PM ET